Argues with vaccines and chooses to reduce dose

This article is more than a month old and may contain outdated advice from authorities regarding coronary heart disease.

Stay updated Overview of NRK, Or by FHIs nettsider.

John Hagen Joel, the chief epidemiologist at Wagon, was a little disappointed.

In recent weeks, they have gained a lot of modernity and little Pfizer. And what they get from Pfizer is that they use it to vaccinate 16- and 17-year-olds.

– Then the dose will be two moderna, says Joel.

But not everyone likes it.

Some have left our vaccination rooms without taking two doses, where they argue with vaccinators about what type they should have.

– Our coordinator or vaccinators can do nothing about this. We are at the mercy of what we can get from the FHI.

No need to worry

Today, the municipality posted information about this on its website.

“Some people want to avoid getting Moderna as Dose 2. We think this is unfortunate and unsubstantiated.” It says.

Joule makes it clear that people have no reason to worry:

– Results in countries where this has been done for a very long time show that there is no high rate of serious side effects. It is the same type of vaccine.

– The security you receive is at least as good.

Provides support

Steiner Matson, the medical director of the Norwegian Medicines Agency, says he himself receives numerous phone calls about it.

People wonder what the risk is and ask for advice.

He can promise:

– These vaccines are linked in many countries and we have a lot of experience. We did not find anything unusual.

– These are two similar vaccines with side effects and level of protection.

Pfizer also says that you must take the vaccine that is given to you:

– From a medical perspective, Norwegian health officials are right: it does not matter which dose of MRNA vaccine is two, the main thing is that it is important that you get vaccinated, Pfizer, the medical director in Norway, told Enrique.

Some numbers: Side effects of the vaccine

Following the administration of 6.4 million doses, 27,830 reports of suspicious reactions were received.

Of these, 15,842 messages were processed. 2456 are classified as serious And 13,386 were classified as non-serious.

The Norwegian pharmaceutical agency monitors the vaccine.

– We receive many reports of side effects. But fortunately there are very few reports of serious side effects, Matson says.

Commenting on last week’s growth, he says:

– There is a steady increase in the number of reports of pericarditis and heart attack. But we waited for it. This is something that primarily affects young people, and now we are starting to vaccinate young people.

– Recipients of this; They are fine. There are only a few cases where this is very serious. We are not worried when we look at the number of side effects associated with the dose.

This is what the FHI says

Khair Bukolm of NIPH says the proportion of the population receiving vaccines from two manufacturers varies between districts and municipalities.

He is the assistant director and head of the vaccination program.

The NIPH also points out that the reports point to “the very high vaccine efficacy of the Moderna vaccine against delta variation”.

– These are the data for the performance of the first dose of Moderna, which is very high. And Moderna Data indicating two-dose efficacy.

We do not have good documentation as to whether the performance of the Pfizer and Moderna combination is equivalent to two doses of Moderna, but we believe that Moderna would benefit from a second dose in a situation where delta variation dominates. Email.

One type is to vaccinate everyone completely otherwise the vaccination program will be delayed for at least 2-3 weeks.

– To the question of whether anyone is skeptical about mixing vaccines, the answer is yes, but many people choose to get vaccinated when they are assured that it does not pose a greater risk than receiving two doses from the same manufacturer.

read more: